Journal of Veterinary Science & Animal Welfare | Volume 2 | Issue 1 | 2017-05-26

Accuracy and Clinical Utility of Selexon™ Canine D-Dimer Device in Measuring of Blood D-Dimer Level in Healthy and Diseased Dogs

Md. Mahbubur Rahman

Abstract

D-dimer is a protein fragment and degradation product of fibrin which is a sensitive tool for early diagnosis of thromboembolic disease such as pulmonary thromboembolism (PTE) and disseminated intravascular coagulation (DIC) both in human and veterinary practice. The objective of this study was to evaluate the accuracy and clinical utility of SelexOn canine D-dimer device (Infopia, Korea) in comparison to the NycoCard D-dimer (Nycomed Pharma AS, Norway). Blood samples were collected from normal (n = 90), clinically ill (n = 33), PTE (n = 40) and DIC (n = 37) diagnosed dogs. The each collected samples were tested with above mentioned two devices and compared to identify any differences. There were no statistically significant differences in D-dimer levels in between two devices either from normal or all diseased dogs. Moreover, the correlation co-efficient was r = + 0.9725. The calculated correlation was significant (p < 0.001) which proves its accuracy. Therefore, SelexOn canine D-dimer device is reliable and suitable device to use for the clinical test for measuring of blood D-dimer concentration in dogs.

Keywords: Selexonâ„¢ D-dimer, NycoCardâ„¢ Internal hemorrhage, Pulmonary hypertension

Full text

D-dimer is a protein fragment consisted with two cross linked D domains from an original fibrinogen. It produced from the cleavage of cross-linked fibrin by plasmin in fibrinolysis process during thrombosis formation. Thrombosis occludes both arteries and veins which are the worldwide underlying leading cause of death. Merely, in the United States, more than 2,000 patients die each day for clot formation in coronary or cerebral arteries which consequence myocardial infarction and stroke [1] . Blood D-dimer represents highly activated coagulation or hemostasis process in various diseases including pulmonary thromboembolism (PTE), disseminated intravascular coagulation (DIC), coronary heart disease and clinically ill patients [2,3] . It is reported that mortality rate in clinically apparent PE is 30% and accounts for 5 10% of all in-hospital deaths, whereas 2 8% mortality rate for treated patients [4] . The prevalence of these diseases is high in the emergency department in human practice but comparatively lower in veterinary practice. However, the actual incidence in veterinary practice is unknown or undiagnosed and may be more common than the available existences in the literature [5] . Interestingly, in recent reportage, D-dimer had been used to detect pathological condition of various diseases in veterinary practices such as DIC [6,7] , thromboembolism [7,8,9,10] , cardiomyopathy [11,12] , chronic congestive heart failure [13] , nephropathy [14] , acute hepatitis [15] , cutaneous vasculitis [16] ), internal hemorrhage, neoplasia, and post-surgically [7] . So, it is well known that DIC is involved with multi-systemic organ failure due to hemostatic activation and microvascular fibrin formation [17] . Thromboembolism (TE) is also considered as one of a fatal complication in clinically severe illness in dogs and cats [18,19] . The available laboratory tests for hemostatic or hypercoagulability diseases are, measurement of clotting times (prothrombin time [PT] and activated partial thromboplastin time [aPTT]), platelet count, fibrinogen and determination of bleeding time [18] . However, they have a lack of sensitivity in the early stages of these diseases [20] . It is the barrier to check complication of thrombotic states such as deep vein thrombosis; atherosclerosis and PTE consequently increased the morbidity and mortality rate. Early diagnosis followed by antithrombotic therapy may improve the mortality in these patients [17,18] . So the scientist focused on developing the new laboratory tests for early diagnosis of hemostasis and prothromboticstates [17] . The measurement of D-dimer is highly sensitive and specific for the rapid diagnosis of early stage active coagulation and fibrinolysis related systemic diseases in dogs [3,12,18] . Immunoenzymatic assay (ELISA), the immuno-turbidimetric assay, and latex agglutination tests are available techniques to measure D-dimer in dogs [9] . The ELISA technique is highly sensitive, but it is not suitable for the emergency case as it is time-consuming as well as it is expertise people and high equipment dependent [21] . Latex agglutination assays have lower sensitivity [22] . Currently, immuno-turbidimetric based sensitive rapid tests are commercially available permitting the optimization of cut-off level for different conditions. SelexOnTM (Infopia, Anyang, Korea) is POCT analyzer utilizing chromatographic immunoassay to quantitatively or qualitatively detect the concentration of more than 30 cardiac, cancer, thyroid and infection markers in human blood such as cardiac troponin I (cTnI), alpha- fetoprotein (AFP), C-reactive protein (CRP), thyroid-stimulating hormone (TSH) [23] and has been working authentically for a long time in the field. Recently, SelexOn canine D-dimer is developed and it is a quantitative device capable of measuring D-dimer in dogs. The objective of this study was to evaluate the clinical utility of SelexOn canine D-dimer in dogs and compared with a comparison to the NycoCard D-dimer (Nycomed Pharma AS, Norway). Materials and Methods Animals and sample collection The dogs (n = 200) which were brought to Seoul local veterinary hospitals by the client for different diseases or for the health assessments were used in this study. 110 dogs had been diagnosed with various diseases (PTE 40, DIC 37 and clinically ill were 33) while 90 of the dogs were healthy. The clinically ill were traumatic injury, neoplasia, hepatic disease and renal disease. The animals were grouped based on clinical findings, imaging tests (ultrasonography, radiography), laboratory results (prolonged PT and aPTT, decreased platelet count, and high D-dimer concentration), blood gas analysis (hypoxia), echocardiographic criteria for pulmonary hypertension, by the expertise veterinarian in the respective hospitals and further carefully examined by the authors in this study. Primarily, blood samples were collected in the test tube containing EDTA for diagnosis or assessments purpose. Secondarily, the remaining blood was used for this study. The clients were informed about that. SelexOn canine D-dimer device (Infopia, Korea) was used to evaluate D-dimer by using blood. Then the remaining blood was centrifuged (3000 RPM for 5 minutes). Then prepared serum was used for D-dimer analysis by NycoCard D-dimer (Nycomed Pharma AS, Norway). Measurement of D-dimer concentration was performed within 0 - 3 hours after sampling. The samples were stored either at 4 C or room temperature for the short-term study. The objective of this study was the evaluation of accuracy and clinical utility of SelexOn canine D-dimer device in D-dimer concentration measurement. Test devices and protocols The following two POCT analyzers were selected for this study: by NycoCard D-dimer (Nycomed Pharma AS, Norway) and SelexOn canine D-dimer (Infopia, Anyang, Korea). NycoCard D-dimer is quantitative test based upon an immunometric flow-through principle by NycoCard Reader II. According to the NycoCard manual, the measuring range of NycoCard D-dimer is 0.1 20.0 mg/L and the cut-off level is 0.3 mg/L. SelexOn canine D-dimer is a sandwich assay using two monoclonal antibodies specific to canine D-dimer and is quantified by the thickness of the test line depending on the color of gold nano particle. EDTA-treated venous whole blood is injected into the blood inlet area of test strip and then the erythrocyte is separated and only plasma is transferred. Target analyte in plasma binds to gold-nanoparticle labelled antibody and then when gold-nanoparticle labelled antibody-target analyte complexes pass through the test line that is immobilized antibody specific to analyte, these produce visible red lines on nitrocellulose membrane The optical system of the SelexOn meter measures the intensity of red lines and the integrated software converts the signal intensity to a quantitative result and shows it on the display. According to the SelexOn manual, the measuring range of canine D-dimer is 100 3000 ng/mL and the cut-off level is 500 ng/mL. Statistical analysis Prism 5.03 software (GraphPad Software Inc., San Diego, CA, USA) were used for statistical analysis of the data. Results are expressed as mean standard deviation of the mean (SD). The paired Student s t-test was used and correlated with the Spearman s rank correlation coefficient. The level of significance was set at p < 0.05. Results and Discussion A total of 200 dogs were included in this study after informing the owners, of these 128 dogs was purebred, including 19 different breeds, and 72 were mixed-breed. 103 of the dogs were male (77 castrated and 26 intact) and 97 of the dogs were female (43 spayed and 54 intact). The age of the 37 dogs were more than 10 years, 121 were over 5 years and 42 dogs were 2 or less than 2 years age. 110 dogs had been diagnosed with various diseases (PTE 40, DIC 37 and 33 were clinically ill) while 90 of the dogs were healthy. All types of dogs were used for sample collection such as different breeds, sex, disease, or healthy were tested and the d-dimer concentration results were compared with NycoCard D-dimer (Nycomed Pharma AS, Norway) which was almost near to this popular devices. In the healthy dogs the average D-dimer level was 140 56 (mean standard deviation) in SelexOn canine D-dimer which is near to NycoCard D-dimer (Nycomed Pharma AS, Norway) (140 62 ng/ml) (Figure 1) indicating its accuracy. The D-dimer concentration level in both devices was within the reference value (0 - 250 ng/ml). DD is the pure degradation products of cross-linked fibrin. Therefore, its concentration in blood is specific for the presence of coagulation, fibrinolysis and thrombosis. Although, thrombosis is thought to be pathological condition but under some circumstances it s considered as an independent line of host defense in physiology that constitutes an intrinsic effect or mechanism of innate immunity. This called immunothrombosis which play an important role in intravascular immunity contributes a wide range of host strategies to detect and protect against pathogens within the vasculature [1,24] . So, it is not strange to present D-dimer in the blood of healthy dogs. Therefore, D-dimer evaluation could be important tools for regular health checkup of dogs and SelexOn canine D-dimer could be reliable device for that purpose. Figure 1: Comparison of the results obtained by SelexOn canine D-dimer and NycoCard D-dimer tests in healthy and diseased dogs. NC, normal healthy; CI, clinically ill; PTE, pulmonary thromboembolism; DIC, disseminated intravascular coagulation.collected from normal (n = 90), clinically ill (n = 33), PTE (n = 40) and DIC (n = 37) diagnosed dogs. The data were analyzed by Bonferroni post hoc testfollowing one-way ANOVA versus the normal control group. There were no significant difference between two groups. However, the regulation of immunothrombosis or balance between fibrin production and lysis is a critical for determining thrombus size, it dysregulation can lead to pathologic condition like DIC, PTE, myocardial infarction, stroke etc. In these pathologic conditions blood D-dimer elevates. D-dimer concentration measurement is specific and important tool in dogs with DIC [6,17,18] . In this study, the average D-dimer in DIC diagnosed dogs was 1891 641 (mean standard deviation) in NycoCard and in SelexOn canine D-dimer was 1844 649 (mean standard deviation) (Figure 1). The data of SelexOn canine D-dimer showed its accuracy and clinical utility in DIC dogs. PTE is another common disease for mortality in dogs [18,19] . Recently, imaging modalities and elevated D-dimer as a laboratory marker are considered as a diagnostic tool for PTE. In this study, D-dimer also elevated level in PTE group. The average levels of D-dimer in the dogs with PTE were 1895 668 (mean standard deviation) in NycoCard and in SelexOn canine D-dimer was 1871 642 (mean standard deviation) (Figure 1). Statistically there was no significant difference between the results of two devices. So, the data of SelexOn canine D-dimer showing its accuracy of measurement of D-dimer level and clinical utility in PTE dogs. It was reported that D-dimer level also elevates in clinically ill dogs (traumatic injury, neoplasia, hepatic disease and renal disease) [17] . Consistently, the average D-dimer level in clinically ill dogs was 532 200 (mean standard deviation) in NycoCard and in SelexOn canine D-dimer was 532 215 (mean standard deviation) (Figure 2) in this study which is comparatively higher than normal healthy dogs. Moreover, there were no statistically significant differences in D-dimer levels in between two devices either from normal or all diseased dogs. In addition, the correlation co-efficient was r = +0.9725. The calculated correlation was significant ( p < 0.001) indicating its accuracy and reliability for clinical use. Figure 2: Spearman s rank correlation between SelexOn canine D-dimer device and NycoCard D-dimer (Alere Technologies AS, Norway) in dogs (n = 200). Conclusion In conclusion, accumulating data in this study from the samples of normal, DIC, PTE or clinically ill dogs prove that the SelexOn canine D-dimer device (Infopia, Korea) promises for optimum accuracy in comparison to the NycoCard D-dimer (Nycomed Pharma AS, Norway) for diagnosis or clinical purpose. Therefore, SelexOn canine D-dimer device is reliable and suitable to use for the clinical test as an alternative to traditional laboratory devices. Competing interests: The authors declare no conflicts of interest. References 1. Engelmann, B., Massberg. S. Thrombosis as an intravascular effector of innate immunity. (2013) Nat Rev Immunol 13(1): 34-45. Pubmed || Crossref || Others 2. Danesh, J., Whincup, P., Walker, M., et al. Fibrin D-dimer and coronary heart disease: prospective study and meta-analysis. (2001) Circulation 103(19): 2323-2327. Pubmed || Crossref || Others 3. Minami, Y., Haruki, S., Jujo, K., et al. Elevated D-dimer levels predict an adverse outcome in hospitalized patients with acute decompensated heart failure. (2016) Int J Cardiol 204: 42-44. Pubmed || Crossref || Others 4. Ben, S.Q., Ni, S.S., Shen, H.H., et al. The dynamic changes of LDH isoenzyme 3 and D-dimer following pulmonary thromboembolism in canine. (2007) Thromb Res 120(4): 575-583. Pubmed || Crossref || Others 5. Goggs, R., Benigni. L., Fuentes, V.L., et al. Pulmonary thromboembolism. (2009) J Vet Emerg Crit Care 19(1): 30-52. Pubmed || Crossref || Others 6. Stokol, T., Brooks, M.B., Erb, H.N., et al. D-dimer concentrations in healthy dogs and dogs with disseminated intravascular coagulation. (2000) Am J Vet Res 61(4): 393-398. Pubmed || Crossref || Others 7. Epstein, S.E., Hopper, K., Mellema, M.S., et al. Diagnostic utility of D-dimer concentrations in dogs with pulmonary embolism. (2013) J Vet Intern Med 27(6): 1646-1649. Pubmed || Crossref || Others 8. Stokol, T. Plasma D-dimer for the diagnosis of thromboembolic disorders in dogs. (2003) Vet Clin North Am Small Anim Pract 33(6): 1419-1435. Pubmed || Crossref || Others 9. Dewhurst, E., Cue, S., Crawford, E., et al. A retrospective study of canine D-dimer concentrations measured using an immunometric "Point-of-Care" test. (2008) J Small Anim Pract 49(7): 344-348. Pubmed || Crossref || Others 10. Machida, T., Kokubu, H., Matsuda, K., et al. Clinical use of D-dimer measurement for the diagnosis of disseminated intravascular coagulation in dogs. (2010) J Vet Med Sci 72(10): 1301-1306. Pubmed || Crossref || Others 11. Park, J., Suh, S.I., Oh, Y., et al. Evaluation of plasma d-dimer concentration in dogs with chronic mitral valve insufficiency. (2015) J Vet Clin 32(1): 5-8. Pubmed || Crossref || Others 12. Stokol, T., Brooks, M., Rush, J.E., et al. Hypercoagulability in cats with cardiomyopathy. (2008) J Vet Intern Med 22(3): 546-552. Pubmed || Crossref || Others 13. Tarnow, I., Falk, T., Tidholm, A., et al. Hemostatic Biomarkers in Dogs with Chronic Congestive Heart Failure. (2007) J Vet Intern Med 21(3): 451-457. Pubmed || Crossref || Others 14. Roumpeas, E., Kostoulas, P., Polizopoulou, Z., et al. D-dimer concentrations in dogs with kidney disease with or without protein-losing nephropathy. (2016) Comp Clin Pathol 25(5): 1007-1011. Pubmed || Crossref || Others 15. Prins, M., Schellens, C.J., van Leeuwen, M.W., et al. Coagulation disorders in dogs with hepatic disease. (2010) Vet J 185(2): 163-168. Pubmed || Crossref || Others 16. Rosser, E.J. Use of the D-dimer assay for diagnosing thrombosis in cases of canine cutaneous vasculitis. (2009) Vet Dermatol 20(5-6): 586-590. Pubmed || Crossref || Others 17. Monreal, L. D-dimer as a new test for the diagnosis of DIC and thromboembolic disease. (2003) J Vet Intern Med 17(6): 757-759. Pubmed || Crossref || Others 18. Nelson, O.L., Andreasen, C. The utility of plasma D-dimer to identify thromboembolic disease in dogs. (2003) J Vet Intern Med 17(6): 830-834. Pubmed || Crossref || Others 19. Kitrell, D., Berkwitt, L. Hypercoagulability in dogs: pathophysiology. (2012) Compend Contin Educ Vet 34(4): E1-E5. Pubmed || Crossref || Others 20. Brazzell, J.L., Borjesson, D.L., Evaluation of plasma antithrombin activity and D-dimer concentration in populations of healthy cats, clinically ill cats, and cats with cardiomyopathy. (2007) Vet Clin Pathol 36(1): 79-84. Pubmed || Crossref || Others 21. Scarano, L., Bernardi, E., Prandoni, P., et al. Accuracy of two newly described D-dimer tests in patients with suspected deep venous thrombosis. (1997) Thromb Res 86(2): 93-99. Pubmed || Crossref || Others 22. Boumameaux, H., De Moerloose, P., Perrier, A., et al. Plasma measurement of D-dimer as diagnostic aid in suspected venous thromboembolism: an overview. (1994) Thromb Haemost 71(1): l-6. Pubmed || Crossref || Others 23. Kim, H.Y., Lee, S.Y., Park, H.D. Performance evaluation of the SelexOn analyser for seven biomarkers. (2014) J Lab Med Qual Assur36:30-38. Pubmed || Crossref || Others 24. Gaertner, F., Massberg, S. Blood coagulation in immunothrombosis-At the frontline of intravascular immunity. (2016) Semin Immunol 28(6): 561-569. Pubmed || Crossref || Others